BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Income Statement

0.000.00%

Last trade - 00:00

UtilitiesSpeculativeSmall CapMomentum Trap

Market Cap
TRY10.00bn
Enterprise Value
TRY14.98bn
Revenue
TRY2.69bn

Annual income statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	245	428	2,338	3,224	2,688
Cost of Revenue
Gross Profit	67.8	123	797	488	119
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	176	377	1,731	2,995	3,052
Operating Profit	69.3	50.9	607	229	-364
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	59.4	23.4	685	1,340	137
Provision for Income Taxes
Net Income After Taxes	49.9	4	577	1,372	98.6
Minority Interest
Net Income Before Extraordinary Items
Net Income	50.5	6.54	577	1,369	98.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	50.5	6.54	577	1,369	98.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.106	0.07	1.16	2.76	0.2
Dividends per Share